In this work, treatment with IL-33 also attenuated hepatic steatosis and reduced ALT levels in mice fed with MCD diet, indicating that the function of IL-33 was not totally dependent on its modulation in glucose metabolism. Here, IL33 is linked to Hepatic steatosis.